Pharmacist-led practice in the management of elderly patients with polypharmacy

doi:10.19803/j.1672-8629.20220518

Abstract

Abstract: Objective To clarify the importance of clinical pharmacists participating in the management of elderly polypharmacy. Methods A multidisciplinary team (MDT) management team for the elderly has been established in our hospital. On this basis, an MDT consultation system and multi-drug clinic has been set up to improve the level of treatment management. Results According to the practice of pharmacists in our hospital in the management of elderly patients with polypharmacy, we explored and established a standardized medication appropriate assessment process, outpatient admission process and prescription streamlining process for patients with polypharmacy. Conclusion The management of elderly patients with polypharmacy is an important part of geriatric pharmacy, and various methods should be taken to improve the management level of elderly patients with polypharmacy.

Key words: polypharmacy, elderly, MDT, prescription streamlining, comprehensive geriatric assessment

CLC Number:

R969.3

ZHU Yuanchao, ZHAO Ming, HU Xin, SHI Hong. Pharmacist-led practice in the management of elderly patients with polypharmacy[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 817-821.

References

[1] United Nations International Population Society. Dictionary of Demography(人口学词典)[M].Beijing: The Commercial Press, 1992.
[2] Percentage of Total Population by Broad Age Groups. World Population Prospects2012[EB/OL]. (2018-11-21)[2021-10-01]. https://population.un.org/wpp/Download/Standard/Population/.
[3] National Bureau of Statistics of the People’s Republic of China. Communiqué of the Seventh National Population Census (No. 5)[EB/OL]. (2021-05-11)(2022-11-30).http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/202106/t20210628_1818824.html.
[4] FRIED TR, NIEHOFF K, TJIA J, et al.A delphi process to address medication appropriateness for older persons with multiple chronic conditions[J]. BMC Geriatr, 2016, 16: 67.
[5] KAUFMAN DW, KELLY JP, ROSENBERG L, et al.Recent patterns of medication use in the ambulatory adult population of the United States: the slone survey[J]. JAMA, 2002, 287(3): 337-344.
[6] WANG K, TANG J, YANG K, et al.A Cross-sectional study on the status of polypharmacy among older Chinese inpatients with chronic diseases in 27 hospitals from 14 provinces[J]. Chin J Pharmacoepidemiol(药物流行病学杂志), 2022, 31(1): 38-44.
[7] XUE ZL, LI H.Investigations of drug use in elderly inpatients[J].Chin J Clin Res(中国临床研究), 2012, 25(1): 79.
[8] YIN LX, ZHANG LH.Special Population Medication Guidance Series: Medication Guidance for the Elderly (特殊人群用药指导丛书:老年人用药指导)[M]. Beijing: People’s Health Publishing House, 2012.
[9] DONG M, ZOU T, XU L, et al.Effects of polypharmacy on long-term prognosis of elderly patients with coronary heart disease and atrial fibrillation[J]. Chin J Pharmacov(中国药物警戒), 2021, 18(2): 126-132.
[10] STEINMAN MA, LANDEFELD CS, ROSENTHAL GE, et al.Polypharmacy and prescribing quality in older people[J]. J Am Geriatr Soc, 2006, 54: 1516-1523.
[11] LIU JH,SHI H,XI H.Thinking about the problem of polypharmacy of the elderly and suggestions on the strategy of drug use for the elderly[J]. Chin J Clin Healthc(中国临床保健杂志), 2018, 21(2): 160-163.
[12] Rational Drug Use Branch of China Association of Geriatric Research. Criteria of potentially inappropriate medication for older adults in China[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2018, 20(1): 2-8.
[13] Geriatric Endocrinology and Metabolic Diseases Branch, Chinese Geriatric Health Care Medical Research Society. Expert consensus on the safety management of polypharmacy in the elderly[J]. Chin Gen Pract(中国全科医学), 2018, 21(29): 3533-3544.
[14] By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc, 2019, 67(4):674-694.
[15] O’MAHONY D, O’SULLIVAN D, BYRNE S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2[J]. Age Ageing, 2015, 44(2):213-218.
[16] MUTH C, HARDER S, UHLMANN L, et al.Pilot study to test the feasibility of a trial design and complex intervention on prioritising multi-medication in multi-morbidity in general practices(PRIMUM pilot)[J]. BMJ Open, 2016, 6(7): e011613.
[17] DRENTH-VAN AC, VAN MARUM RJ, KNOL W, et al.Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners[J]. Drugs Aging, 2009, 26(8): 687-701.
[18] HAQUE R.ARMOR: a tool to evaluate polypharmacy in elderly persons[J]. Annals of Long-Term Care, 2009, 17(6): 26.
[19] KOMAGAMINE J, SUGAWARA K, KAMINAGA M, et al.Study protocol for a single-center, prospective, non-blinded, randomised, 12-month, parallel-group superiority study to compare the efficacy of pharmacist intervention versus usual care for elderly patients hospitalised in orthopaedic wards[J]. BMJ Open, 2018, 8(7): e021924.
[20] SHIM YW, CHUA SS, WONG HC, et al.Collaborative intervention between pharmacists and physicians on elderly patients: a randomized controlled trial[J]. Ther Clin Risk Manag, 2018, 14: 1115-1125.
[21] SCOTT IA, HILMER SN, REEVE E, et al.Reducing inappropriate polypharmacy: the process of deprescribing[J]. JAMA Intern Med, 2015, 175(5): 827-834.
[22] SCOTT IA, PILLANS PI, BARRAS M, et al.Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review[J]. Ther Adv Drug Saf, 2018, 9(9): 559-573.
[23] LI WJ, YAN YY, YI ZM, et al.Retrospective study on the effect of deprescribing in elderl y inpatients with polypharmcy[J]. Chin Hosp Pharm J(中国医院药学杂志), 2021, 41(9): 944-947.
[24] KALUNGIA AC, KAMANGA T.Patients’satisfaction with outpatient pharmacy services at the University Teaching Hospital and Ndola Central Hospital in Zambia[J]. J Prevent Rehabilitat Med, 2016, 15: 229-230.
[25] ZHAI WJ, WANG S, GUO BR, et al.Investigation and analysis of satisfaction of patients in pharmacy outpatients[J]. Chinese Remedies & Clinics(中国药物与临床), 2022, 22(5): 439-442.
[26] National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Opinions on accelerating the high-quality development of pharmaceutical services[EB/OL]. (2018-11-21)[2021-10-01]. http://www.nhc.gov.cn/yzygj/s7659/201811/ac342952cc114bd094fec1be086d2245.shtml.
[27] WANG CY, HUANG YK, XI XY, et al.Literature review on implementation modes of practicing for clinical pharmacists in China[J]. Chin J Hosp Pharm(中国医院药学杂志), 2021, 41(16): 1595-1600.
[28] YANG LH, WEN ZY, LIU MC, et al.Experience of multi-disciplinary team mode in 40 tertiary public hospitals in China[J]. Chin J Hosp Admin(中华医院管理杂志), 2021, 37(6): 505-508.
[29] DAI J, JI C, LI LT, et al.Effect of multi-disciplinary cooperative blood glucose management model involving clinical pharmacists on perioperative glucose controls[J]. Chin Hosp Pharm J(中国医院药学杂志), 2021, 41(2): 215-219.
[30] HU XL, ZHAN SP, WANG Y, et al.Polypharmacy management and pharmaceutical care of clinical pharmacists participating in the team of comprehensive geriatric assessment[J]. Chin Pharm J(中国药学杂志), 2017, 52(4): 323-326.
[31] LIU H, XIA W, CHEN WJ, et al.Quality improvement of home-based pharmaceutical care[J]. Chin Pharm(中国药业), 2022, 31(4): 32-36.
[32] JIA BY, ZHOU S, ZHOU Y, et al.Systematic evaluation and meta-analysis of the effect of home pharmaceutical care in elderly patients with poypharmacy[J]. Chin Hosp Pharm J(中国医院药学杂志), 2022, 2: 189-195.